Studies related to Cancer risk and Ginkgo biloba

Ginkgo Biloba And Risk Of Cancer: Secondary Analysis Of The Ginkgo Evaluation Of Memory (GEM) Study

Effect None
Trial Design Double blind
Trial Length 6+ Months
Number of Subjects 3069
Sex Both Genders
Age Range 65+
Body Types Overweight, Average
Notes for this study:
In an analysis of a study where 240mg EGb-761 was given to persons over the age of 75 for the purpose of cognitive decline, there was no significant protective effect of ginkgo on cancer incidence over the course of 6.1 years. There was a nonsignificant trend to increase breast and colon cancer risk while reducing prostate cancer risk, and this increased risk for breast cancer reached significance (hazard ratio of 2.5 with a 95% CI of 1.03–6.07) when observation was started 1 year after randomization.